58. Hypertrophic cardiomyopathy Clinical trials / Disease details

Clinical trials : 119 / Drugs : 163 - (DrugBank : 45) / Drug target genes : 48 - Drug target pathways : 161

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03259113 (ClinicalTrials.gov)	August 16, 2017	19/8/2017	Insertable Cardiac Monitors in Hypertrophic Cardiomyopathy	EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic CardioMyopathy	Hypertrophic Cardiomyopathy	Device: Insertable cardiac monitor	Region Gävleborg	St. Jude Medical;Norrlands University Hospital	Recruiting	18 Years	65 Years	All	30	N/A	Sweden
2	NCT02862600 (ClinicalTrials.gov)	August 1, 2016	8/8/2016	Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure	A Phase 2, Multi-Center, Open-Label, Ascending Dose Study on the Efficacy, Safety and Tolerability of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure With Preserved Left Ventricular Function	Cardiomyopathy, Hypertrophic;Cardiomyopathy, Hypertrophic, Familial	Drug: Perhexiline;Device: Use of bioanalytical assay to monitor plasma levels of perhexiline	Heart Metabolics Limited	NULL	Terminated	18 Years	N/A	All	35	Phase 2	United States